Global T-Cell Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

Page: 103

Published Date: 11 Jan 2023

Category: Medical Care

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Related Reports
Product Tags

Description

According to our (Global Info Research) latest study, the global T-Cell Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global T-Cell Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global T-Cell Therapy market size and forecasts, in consumption value ($ Million), 2018-2029
Global T-Cell Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global T-Cell Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global T-Cell Therapy market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for T-Cell Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global T-Cell Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Gilead Sciences, Inc., Sorrento Therapeutics, Fate Therapeutics Inc., Novartis International AG and AbbVie Inc., etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation
T-Cell Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
CAR T Cell Therapy
TCR Therapy
TIL Therapy

Market segment by Application
Hospitals
Clinics & Ambulatory Centers
Cancer Research Institutes
Others

Market segment by players, this report covers
Gilead Sciences, Inc.
Sorrento Therapeutics
Fate Therapeutics Inc.
Novartis International AG
AbbVie Inc.
Adaptimmune Therapeutics PLC
Bluebird Bio
TCR2 Therapeutics, Inc.
Pfizer Inc.
DiaCarta, Inc.

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe T-Cell Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of T-Cell Therapy, with revenue, gross margin and global market share of T-Cell Therapy from 2018 to 2023.
Chapter 3, the T-Cell Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and T-Cell Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of T-Cell Therapy.
Chapter 13, to describe T-Cell Therapy research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope of T-Cell Therapy
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of T-Cell Therapy by Type
        1.3.1 Overview: Global T-Cell Therapy Market Size by Type: 2018 Versus 2022 Versus 2029
        1.3.2 Global T-Cell Therapy Consumption Value Market Share by Type in 2022
        1.3.3 CAR T Cell Therapy
        1.3.4 TCR Therapy
        1.3.5 TIL Therapy
    1.4 Global T-Cell Therapy Market by Application
        1.4.1 Overview: Global T-Cell Therapy Market Size by Application: 2018 Versus 2022 Versus 2029
        1.4.2 Hospitals
        1.4.3 Clinics & Ambulatory Centers
        1.4.4 Cancer Research Institutes
        1.4.5 Others
    1.5 Global T-Cell Therapy Market Size & Forecast
    1.6 Global T-Cell Therapy Market Size and Forecast by Region
        1.6.1 Global T-Cell Therapy Market Size by Region: 2018 VS 2022 VS 2029
        1.6.2 Global T-Cell Therapy Market Size by Region, (2018-2029)
        1.6.3 North America T-Cell Therapy Market Size and Prospect (2018-2029)
        1.6.4 Europe T-Cell Therapy Market Size and Prospect (2018-2029)
        1.6.5 Asia-Pacific T-Cell Therapy Market Size and Prospect (2018-2029)
        1.6.6 South America T-Cell Therapy Market Size and Prospect (2018-2029)
        1.6.7 Middle East and Africa T-Cell Therapy Market Size and Prospect (2018-2029)

2 Company Profiles
    2.1 Gilead Sciences, Inc.
        2.1.1 Gilead Sciences, Inc. Details
        2.1.2 Gilead Sciences, Inc. Major Business
        2.1.3 Gilead Sciences, Inc. T-Cell Therapy Product and Solutions
        2.1.4 Gilead Sciences, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.1.5 Gilead Sciences, Inc. Recent Developments and Future Plans
    2.2 Sorrento Therapeutics
        2.2.1 Sorrento Therapeutics Details
        2.2.2 Sorrento Therapeutics Major Business
        2.2.3 Sorrento Therapeutics T-Cell Therapy Product and Solutions
        2.2.4 Sorrento Therapeutics T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.2.5 Sorrento Therapeutics Recent Developments and Future Plans
    2.3 Fate Therapeutics Inc.
        2.3.1 Fate Therapeutics Inc. Details
        2.3.2 Fate Therapeutics Inc. Major Business
        2.3.3 Fate Therapeutics Inc. T-Cell Therapy Product and Solutions
        2.3.4 Fate Therapeutics Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.3.5 Fate Therapeutics Inc. Recent Developments and Future Plans
    2.4 Novartis International AG
        2.4.1 Novartis International AG Details
        2.4.2 Novartis International AG Major Business
        2.4.3 Novartis International AG T-Cell Therapy Product and Solutions
        2.4.4 Novartis International AG T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.4.5 Novartis International AG Recent Developments and Future Plans
    2.5 AbbVie Inc.
        2.5.1 AbbVie Inc. Details
        2.5.2 AbbVie Inc. Major Business
        2.5.3 AbbVie Inc. T-Cell Therapy Product and Solutions
        2.5.4 AbbVie Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.5.5 AbbVie Inc. Recent Developments and Future Plans
    2.6 Adaptimmune Therapeutics PLC
        2.6.1 Adaptimmune Therapeutics PLC Details
        2.6.2 Adaptimmune Therapeutics PLC Major Business
        2.6.3 Adaptimmune Therapeutics PLC T-Cell Therapy Product and Solutions
        2.6.4 Adaptimmune Therapeutics PLC T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.6.5 Adaptimmune Therapeutics PLC Recent Developments and Future Plans
    2.7 Bluebird Bio
        2.7.1 Bluebird Bio Details
        2.7.2 Bluebird Bio Major Business
        2.7.3 Bluebird Bio T-Cell Therapy Product and Solutions
        2.7.4 Bluebird Bio T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.7.5 Bluebird Bio Recent Developments and Future Plans
    2.8 TCR2 Therapeutics, Inc.
        2.8.1 TCR2 Therapeutics, Inc. Details
        2.8.2 TCR2 Therapeutics, Inc. Major Business
        2.8.3 TCR2 Therapeutics, Inc. T-Cell Therapy Product and Solutions
        2.8.4 TCR2 Therapeutics, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.8.5 TCR2 Therapeutics, Inc. Recent Developments and Future Plans
    2.9 Pfizer Inc.
        2.9.1 Pfizer Inc. Details
        2.9.2 Pfizer Inc. Major Business
        2.9.3 Pfizer Inc. T-Cell Therapy Product and Solutions
        2.9.4 Pfizer Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.9.5 Pfizer Inc. Recent Developments and Future Plans
    2.10 DiaCarta, Inc.
        2.10.1 DiaCarta, Inc. Details
        2.10.2 DiaCarta, Inc. Major Business
        2.10.3 DiaCarta, Inc. T-Cell Therapy Product and Solutions
        2.10.4 DiaCarta, Inc. T-Cell Therapy Revenue, Gross Margin and Market Share (2018-2023)
        2.10.5 DiaCarta, Inc. Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global T-Cell Therapy Revenue and Share by Players (2018-2023)
    3.2 Market Share Analysis (2022)
        3.2.1 Market Share of T-Cell Therapy by Company Revenue
        3.2.2 Top 3 T-Cell Therapy Players Market Share in 2022
        3.2.3 Top 6 T-Cell Therapy Players Market Share in 2022
    3.3 T-Cell Therapy Market: Overall Company Footprint Analysis
        3.3.1 T-Cell Therapy Market: Region Footprint
        3.3.2 T-Cell Therapy Market: Company Product Type Footprint
        3.3.3 T-Cell Therapy Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global T-Cell Therapy Consumption Value and Market Share by Type (2018-2023)
    4.2 Global T-Cell Therapy Market Forecast by Type (2024-2029)

5 Market Size Segment by Application
    5.1 Global T-Cell Therapy Consumption Value Market Share by Application (2018-2023)
    5.2 Global T-Cell Therapy Market Forecast by Application (2024-2029)

6 North America
    6.1 North America T-Cell Therapy Consumption Value by Type (2018-2029)
    6.2 North America T-Cell Therapy Consumption Value by Application (2018-2029)
    6.3 North America T-Cell Therapy Market Size by Country
        6.3.1 North America T-Cell Therapy Consumption Value by Country (2018-2029)
        6.3.2 United States T-Cell Therapy Market Size and Forecast (2018-2029)
        6.3.3 Canada T-Cell Therapy Market Size and Forecast (2018-2029)
        6.3.4 Mexico T-Cell Therapy Market Size and Forecast (2018-2029)

7 Europe
    7.1 Europe T-Cell Therapy Consumption Value by Type (2018-2029)
    7.2 Europe T-Cell Therapy Consumption Value by Application (2018-2029)
    7.3 Europe T-Cell Therapy Market Size by Country
        7.3.1 Europe T-Cell Therapy Consumption Value by Country (2018-2029)
        7.3.2 Germany T-Cell Therapy Market Size and Forecast (2018-2029)
        7.3.3 France T-Cell Therapy Market Size and Forecast (2018-2029)
        7.3.4 United Kingdom T-Cell Therapy Market Size and Forecast (2018-2029)
        7.3.5 Russia T-Cell Therapy Market Size and Forecast (2018-2029)
        7.3.6 Italy T-Cell Therapy Market Size and Forecast (2018-2029)

8 Asia-Pacific
    8.1 Asia-Pacific T-Cell Therapy Consumption Value by Type (2018-2029)
    8.2 Asia-Pacific T-Cell Therapy Consumption Value by Application (2018-2029)
    8.3 Asia-Pacific T-Cell Therapy Market Size by Region
        8.3.1 Asia-Pacific T-Cell Therapy Consumption Value by Region (2018-2029)
        8.3.2 China T-Cell Therapy Market Size and Forecast (2018-2029)
        8.3.3 Japan T-Cell Therapy Market Size and Forecast (2018-2029)
        8.3.4 South Korea T-Cell Therapy Market Size and Forecast (2018-2029)
        8.3.5 India T-Cell Therapy Market Size and Forecast (2018-2029)
        8.3.6 Southeast Asia T-Cell Therapy Market Size and Forecast (2018-2029)
        8.3.7 Australia T-Cell Therapy Market Size and Forecast (2018-2029)

9 South America
    9.1 South America T-Cell Therapy Consumption Value by Type (2018-2029)
    9.2 South America T-Cell Therapy Consumption Value by Application (2018-2029)
    9.3 South America T-Cell Therapy Market Size by Country
        9.3.1 South America T-Cell Therapy Consumption Value by Country (2018-2029)
        9.3.2 Brazil T-Cell Therapy Market Size and Forecast (2018-2029)
        9.3.3 Argentina T-Cell Therapy Market Size and Forecast (2018-2029)

10 Middle East & Africa
    10.1 Middle East & Africa T-Cell Therapy Consumption Value by Type (2018-2029)
    10.2 Middle East & Africa T-Cell Therapy Consumption Value by Application (2018-2029)
    10.3 Middle East & Africa T-Cell Therapy Market Size by Country
        10.3.1 Middle East & Africa T-Cell Therapy Consumption Value by Country (2018-2029)
        10.3.2 Turkey T-Cell Therapy Market Size and Forecast (2018-2029)
        10.3.3 Saudi Arabia T-Cell Therapy Market Size and Forecast (2018-2029)
        10.3.4 UAE T-Cell Therapy Market Size and Forecast (2018-2029)

11 Market Dynamics
    11.1 T-Cell Therapy Market Drivers
    11.2 T-Cell Therapy Market Restraints
    11.3 T-Cell Therapy Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry
    11.5 Influence of COVID-19 and Russia-Ukraine War
        11.5.1 Influence of COVID-19
        11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis
    12.1 T-Cell Therapy Industry Chain
    12.2 T-Cell Therapy Upstream Analysis
    12.3 T-Cell Therapy Midstream Analysis
    12.4 T-Cell Therapy Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Global T-Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Table 2. Global T-Cell Therapy Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
    Table 3. Global T-Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 4. Global T-Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 5. Gilead Sciences, Inc. Company Information, Head Office, and Major Competitors
    Table 6. Gilead Sciences, Inc. Major Business
    Table 7. Gilead Sciences, Inc. T-Cell Therapy Product and Solutions
    Table 8. Gilead Sciences, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 9. Gilead Sciences, Inc. Recent Developments and Future Plans
    Table 10. Sorrento Therapeutics Company Information, Head Office, and Major Competitors
    Table 11. Sorrento Therapeutics Major Business
    Table 12. Sorrento Therapeutics T-Cell Therapy Product and Solutions
    Table 13. Sorrento Therapeutics T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 14. Sorrento Therapeutics Recent Developments and Future Plans
    Table 15. Fate Therapeutics Inc. Company Information, Head Office, and Major Competitors
    Table 16. Fate Therapeutics Inc. Major Business
    Table 17. Fate Therapeutics Inc. T-Cell Therapy Product and Solutions
    Table 18. Fate Therapeutics Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 19. Fate Therapeutics Inc. Recent Developments and Future Plans
    Table 20. Novartis International AG Company Information, Head Office, and Major Competitors
    Table 21. Novartis International AG Major Business
    Table 22. Novartis International AG T-Cell Therapy Product and Solutions
    Table 23. Novartis International AG T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 24. Novartis International AG Recent Developments and Future Plans
    Table 25. AbbVie Inc. Company Information, Head Office, and Major Competitors
    Table 26. AbbVie Inc. Major Business
    Table 27. AbbVie Inc. T-Cell Therapy Product and Solutions
    Table 28. AbbVie Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 29. AbbVie Inc. Recent Developments and Future Plans
    Table 30. Adaptimmune Therapeutics PLC Company Information, Head Office, and Major Competitors
    Table 31. Adaptimmune Therapeutics PLC Major Business
    Table 32. Adaptimmune Therapeutics PLC T-Cell Therapy Product and Solutions
    Table 33. Adaptimmune Therapeutics PLC T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 34. Adaptimmune Therapeutics PLC Recent Developments and Future Plans
    Table 35. Bluebird Bio Company Information, Head Office, and Major Competitors
    Table 36. Bluebird Bio Major Business
    Table 37. Bluebird Bio T-Cell Therapy Product and Solutions
    Table 38. Bluebird Bio T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 39. Bluebird Bio Recent Developments and Future Plans
    Table 40. TCR2 Therapeutics, Inc. Company Information, Head Office, and Major Competitors
    Table 41. TCR2 Therapeutics, Inc. Major Business
    Table 42. TCR2 Therapeutics, Inc. T-Cell Therapy Product and Solutions
    Table 43. TCR2 Therapeutics, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 44. TCR2 Therapeutics, Inc. Recent Developments and Future Plans
    Table 45. Pfizer Inc. Company Information, Head Office, and Major Competitors
    Table 46. Pfizer Inc. Major Business
    Table 47. Pfizer Inc. T-Cell Therapy Product and Solutions
    Table 48. Pfizer Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 49. Pfizer Inc. Recent Developments and Future Plans
    Table 50. DiaCarta, Inc. Company Information, Head Office, and Major Competitors
    Table 51. DiaCarta, Inc. Major Business
    Table 52. DiaCarta, Inc. T-Cell Therapy Product and Solutions
    Table 53. DiaCarta, Inc. T-Cell Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2023)
    Table 54. DiaCarta, Inc. Recent Developments and Future Plans
    Table 55. Global T-Cell Therapy Revenue (USD Million) by Players (2018-2023)
    Table 56. Global T-Cell Therapy Revenue Share by Players (2018-2023)
    Table 57. Breakdown of T-Cell Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
    Table 58. Market Position of Players in T-Cell Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
    Table 59. Head Office of Key T-Cell Therapy Players
    Table 60. T-Cell Therapy Market: Company Product Type Footprint
    Table 61. T-Cell Therapy Market: Company Product Application Footprint
    Table 62. T-Cell Therapy New Market Entrants and Barriers to Market Entry
    Table 63. T-Cell Therapy Mergers, Acquisition, Agreements, and Collaborations
    Table 64. Global T-Cell Therapy Consumption Value (USD Million) by Type (2018-2023)
    Table 65. Global T-Cell Therapy Consumption Value Share by Type (2018-2023)
    Table 66. Global T-Cell Therapy Consumption Value Forecast by Type (2024-2029)
    Table 67. Global T-Cell Therapy Consumption Value by Application (2018-2023)
    Table 68. Global T-Cell Therapy Consumption Value Forecast by Application (2024-2029)
    Table 69. North America T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 70. North America T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 71. North America T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 72. North America T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 73. North America T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 74. North America T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 75. Europe T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 76. Europe T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 77. Europe T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 78. Europe T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 79. Europe T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 80. Europe T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 81. Asia-Pacific T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 82. Asia-Pacific T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 83. Asia-Pacific T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 84. Asia-Pacific T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 85. Asia-Pacific T-Cell Therapy Consumption Value by Region (2018-2023) & (USD Million)
    Table 86. Asia-Pacific T-Cell Therapy Consumption Value by Region (2024-2029) & (USD Million)
    Table 87. South America T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 88. South America T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 89. South America T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 90. South America T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 91. South America T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 92. South America T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 93. Middle East & Africa T-Cell Therapy Consumption Value by Type (2018-2023) & (USD Million)
    Table 94. Middle East & Africa T-Cell Therapy Consumption Value by Type (2024-2029) & (USD Million)
    Table 95. Middle East & Africa T-Cell Therapy Consumption Value by Application (2018-2023) & (USD Million)
    Table 96. Middle East & Africa T-Cell Therapy Consumption Value by Application (2024-2029) & (USD Million)
    Table 97. Middle East & Africa T-Cell Therapy Consumption Value by Country (2018-2023) & (USD Million)
    Table 98. Middle East & Africa T-Cell Therapy Consumption Value by Country (2024-2029) & (USD Million)
    Table 99. T-Cell Therapy Raw Material
    Table 100. Key Suppliers of T-Cell Therapy Raw Materials
List of Figures
    Figure 1. T-Cell Therapy Picture
    Figure 2. Global T-Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 3. Global T-Cell Therapy Consumption Value Market Share by Type in 2022
    Figure 4. CAR T Cell Therapy
    Figure 5. TCR Therapy
    Figure 6. TIL Therapy
    Figure 7. Global T-Cell Therapy Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
    Figure 8. T-Cell Therapy Consumption Value Market Share by Application in 2022
    Figure 9. Hospitals Picture
    Figure 10. Clinics & Ambulatory Centers Picture
    Figure 11. Cancer Research Institutes Picture
    Figure 12. Others Picture
    Figure 13. Global T-Cell Therapy Consumption Value, (USD Million): 2018 & 2022 & 2029
    Figure 14. Global T-Cell Therapy Consumption Value and Forecast (2018-2029) & (USD Million)
    Figure 15. Global Market T-Cell Therapy Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
    Figure 16. Global T-Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 17. Global T-Cell Therapy Consumption Value Market Share by Region in 2022
    Figure 18. North America T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 19. Europe T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 20. Asia-Pacific T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 21. South America T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 22. Middle East and Africa T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 23. Global T-Cell Therapy Revenue Share by Players in 2022
    Figure 24. T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
    Figure 25. Global Top 3 Players T-Cell Therapy Market Share in 2022
    Figure 26. Global Top 6 Players T-Cell Therapy Market Share in 2022
    Figure 27. Global T-Cell Therapy Consumption Value Share by Type (2018-2023)
    Figure 28. Global T-Cell Therapy Market Share Forecast by Type (2024-2029)
    Figure 29. Global T-Cell Therapy Consumption Value Share by Application (2018-2023)
    Figure 30. Global T-Cell Therapy Market Share Forecast by Application (2024-2029)
    Figure 31. North America T-Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 32. North America T-Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 33. North America T-Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 34. United States T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 35. Canada T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 36. Mexico T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 37. Europe T-Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 38. Europe T-Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 39. Europe T-Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 40. Germany T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 41. France T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 42. United Kingdom T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 43. Russia T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 44. Italy T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 45. Asia-Pacific T-Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 46. Asia-Pacific T-Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 47. Asia-Pacific T-Cell Therapy Consumption Value Market Share by Region (2018-2029)
    Figure 48. China T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 49. Japan T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 50. South Korea T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 51. India T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 52. Southeast Asia T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 53. Australia T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 54. South America T-Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 55. South America T-Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 56. South America T-Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 57. Brazil T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 58. Argentina T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 59. Middle East and Africa T-Cell Therapy Consumption Value Market Share by Type (2018-2029)
    Figure 60. Middle East and Africa T-Cell Therapy Consumption Value Market Share by Application (2018-2029)
    Figure 61. Middle East and Africa T-Cell Therapy Consumption Value Market Share by Country (2018-2029)
    Figure 62. Turkey T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 63. Saudi Arabia T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 64. UAE T-Cell Therapy Consumption Value (2018-2029) & (USD Million)
    Figure 65. T-Cell Therapy Market Drivers
    Figure 66. T-Cell Therapy Market Restraints
    Figure 67. T-Cell Therapy Market Trends
    Figure 68. Porters Five Forces Analysis
    Figure 69. Manufacturing Cost Structure Analysis of T-Cell Therapy in 2022
    Figure 70. Manufacturing Process Analysis of T-Cell Therapy
    Figure 71. T-Cell Therapy Industrial Chain
    Figure 72. Methodology
    Figure 73. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Related Reports

Global T-Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global T-Cell Therapy Market 2024 by Company, Regions, Type and Application, Forecast to 2030

date 08 Jan 2024

date Medical Care

According to our (Global Info Research) latest study, the global T-Cell Therapy market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

Product Tags

CAR T-Cell Therapy

CAR T-cell Therapy Drug

Chimeric Antigen Receptor T Cell Therapy

CAR T-Cell Therapy Agents

Chimeric Antigen Receptor (CAR) T-Cell Therapy

T-Cell Therapy

Chimeric Antigen Receptor (CAR)-T Cell Therapy

CAR-T Cell Therapy Solution

CAR T-Cell Therapy for Multiple Myeloma

CAR-T Cell Therapy

Pediatric CAR T-cell Therapy

Aldult CAR T-cell Therapy

Autologous CAR-T Cell Therapy

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>